News & Events :: SCYNEXIS, Inc. (SCYX)

Skip to main content Skip to section navigation Skip to footer

Recent News

Dec 18, 2024 8:00am EST

SCYNEXIS Initiates Dosing in Phase 1 Trial of SCY-247, a Second-Generation Fungerp Candidate for Invasive Fungal Infections

Nov 6, 2024 4:30pm EST

SCYNEXIS Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Recent Events

View All Events

Nov 12, 2024

Guggenheim Securities Healthcare Conference

View All Events

Latest Presentation

View All Presentations

Nov 7, 2024

Investor Presentation

View All Presentations

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings